Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
Condition: Bronchopulmonary Dysplasia Intervention: Drug: Evaluation at 24 months corrected age: respiratory outcome, Neurodevelopmental outcome, Growth outcome Sponsor: Hospices Civils de Lyon Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Bronchopulmonary Dysplasia | Corticosteroid Therapy | Neurology | Research | Respiratory Medicine